Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05563558
Title Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS) (PEAPOD_FOS)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Fundacion Oncosur
Age Groups: adult | senior
Covered Countries ESP

No variant requirements are available.